

Fundamental dimension Equity attribute | ATHHFPeer $0.0060.00% Cap $454.1KP/E -1.2x QuantScore20/100 | AMTYLeader $0.026▼-2.26% Cap $2.15MP/E 23.6x QuantScore51/100 | BRVOPeer $0.0190.00% Cap $905.2KP/E -2.8x QuantScore19/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
61/100 |
59/100 |
25/100 |
Valuation Multiples, PEG & DCF upside | 0/100 | 87/100 | 25/100 |
Health Piotroski, Altman Z, leverage & liquidity | 20/100 | 46/100 | 25/100 |
Growth Revenue / earnings growth & margins | 0/100 | 12/100 | 0/100 |
Sentiment Analyst ratings, targets & revisions | — | — | — |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | -1.2x | 23.6x | -2.8x |
Forward P/E (next FY) | — | — | — |
EV / EBITDA (TTM) | -2.4x | 16.5x | -2.6x |
Price / Sales | — | 0.5x | — |
Price / Free Cash Flow | -2.0x | 10.4x | 60.1x |
PEG ratio | -0.06 | -0.06 | 0.04 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 2 / 9 | 5 / 9 | 2 / 9 |
Altman Z-Score | -32.49 (Distress) | -6.83 (Distress) | -58844.59 (Distress) |
Total debt / equity | -1.00 | 1.37 | 0.00 |
Quick ratio | 0.2x | 2.7x | — |
Interest coverage | -13.0x | — | — |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | — | +9.2% | — |
Net income growth YoY | -34.7% | -64.2% | -164.4% |
Gross margin (TTM) | 0.0% | 27.2% | 0.0% |
Operating margin (FY) | — | 1.5% | — |
FCF margin (FY) | — | 4.6% | — |
5. Trailing price performancePrice change over period |
1M return | -30.0% | 0.0% | -36.7% |
3M return | -10.1% | -35.0% | -42.4% |
6M return | -64.3% | -32.5% | -38.7% |
Year to date | -85.9% | -35.0% | -38.7% |
1Y return | -89.2% | -37.3% | -59.7% |
3Y return | -88.0% | -28.0% | -87.0% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $-0.0054 -189.6% premium | $0.1331 +412.0% upside | $-0.0026 -113.5% premium |
Wall Street consensus target | — — | — — | — — |
Consensus stance | — | — | — |